Hair Loss Treatments in AI Search: The Biggest AI Visibility Problems and How We'd Fix Them

Mark HuntleyBy Mark HuntleyFounder and CEO
21 minutes read

Key Takeaways

  • Rogaine and Hims lead the category in mentions, recommendations, and first-place placements.
  • Nutrafol is frequently recommended, but it appears less often as the top answer than Rogaine or Hims.
  • Keeps and Bosley have notable visibility gaps, with several high-priority factual conflicts to verify.
  • The recommended next steps are baseline tracking, primary-source fact checks, owned-page reviews, and targeted publisher reviews.

Companies covered: Ro, Hims, Keeps, Bosley, Folexin, Rogaine, HairClub, Nutrafol, Happy Head, Propecia (Merck)

Answer Capsule

The November 2026 Hair Loss Treatments benchmark compares 10 companies across 722 AI answers that met its inclusion rules. Rogaine recorded 547 mentions and 341 recommendations (47.23% of the answers). Being mentioned means appearing in an answer; being recommended means receiving an affirmative endorsement.

We examine each company, establish the current research baseline, and set out a five-step plan for improving the information AI systems can draw on. The work starts with measuring visibility and checking conflicting claims, then moves to company pages, relevant publishers and buyer questions. The cited pages need review before any correction request, and the research does not establish what caused recommendation differences or promise future gains.

Executive industry diagnosis

Questions This Section Answers

  • What does the Hair Loss Treatments benchmark show about mentions, recommendations and placement?

Rank

Company

Mentions

Mention rate

Recommendations

Recommendation rate

Top 3

Top 3 rate

#1

#1 rate

1

Rogaine

547

75.76%

341

47.23%

269

37.26%

227

31.44%

2

Hims

534

73.96%

322

44.60%

262

36.29%

124

17.17%

3

Nutrafol

395

54.71%

274

37.95%

203

28.12%

30

4.16%

4

Happy Head

220

30.47%

156

21.61%

122

16.90%

10

1.39%

5

Keeps

239

33.10%

125

17.31%

88

12.19%

14

1.94%

6

Propecia (Merck)

302

41.83%

105

14.54%

80

11.08%

24

3.32%

7

Ro

163

22.58%

77

10.66%

55

7.62%

14

1.94%

8

Bosley

56

7.76%

11

1.52%

6

0.83%

2

0.28%

9

HairClub

40

5.54%

3

0.42%

2

0.28%

0

0.00%

10

Folexin

2

0.28%

2

0.28%

2

0.28%

1

0.14%

The peer set splits into two tiers. Rogaine and Hims appear in roughly three-quarters of answers and are endorsed in close to half, while Nutrafol sits just behind them. The remaining brands appear far less often and are endorsed at much lower rates, so visibility and endorsement move together at the top but not uniformly below it.

Placement adds a second distinction. Rogaine and Hims also dominate first-place answers, whereas Nutrafol and Happy Head are recommended often but rarely lead. A brand can therefore be a common answer without being the answer, and the two outcomes deserve separate attention in planning.

Keeps and Propecia (Merck) show a different imbalance: both appear in a meaningful share of answers but are endorsed well below their mention levels. Bosley, HairClub and Folexin sit at the edge of the set, with few appearances and fewer endorsements. The agency would treat these as distinct starting positions rather than one ranking to chase.

What changed since last month

Questions This Section Answers

  • What changed across the usable monthly Hair Loss Treatments snapshots?

Company

Nov 2026

Rogaine

341 / 722 (47.23%)

Hims

322 / 722 (44.60%)

Nutrafol

274 / 722 (37.95%)

Happy Head

156 / 722 (21.61%)

Keeps

125 / 722 (17.31%)

Propecia (Merck)

105 / 722 (14.54%)

Ro

77 / 722 (10.66%)

Bosley

11 / 722 (1.52%)

HairClub

3 / 722 (0.42%)

Folexin

2 / 722 (0.28%)

Only months with verified results are shown. Monthly sample coverage is listed in Methodology.

This edition is the first broad baseline, so the monthly figures describe one selected sample rather than a movement from earlier editions. Earlier editions used a narrower question set, and their numbers stay in the archive without being read as a trend.

The observed differences between companies are therefore a snapshot of this sample. A different answer total in a future edition would not by itself establish why counts or rates changed. The agency would document the screening scope now so later editions can be compared on the same footing.

AI recommendation trend

Observed recommendation rate (%), Nov 2026

  • Rogaineno change
    Nov 202647.23%
  • Himsno change
    Nov 202644.60%
  • Nutrafolno change
    Nov 202637.95%
  • Happy Headno change
    Nov 202621.61%
  • Keepsno change
    Nov 202617.31%
  • Propecia (Merck)no change
    Nov 202614.54%
  • Rono change
    Nov 202610.66%
  • Bosleyno change
    Nov 20261.52%
  • HairClubno change
    Nov 20260.42%
  • Folexinno change
    Nov 20260.28%

Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.

Company-by-company findings

Ro

Questions This Section Answers

  • What measured visibility pattern and review priority does Ro have in Hair Loss Treatments?

Ro recorded 163 mentions (22.58%) and 77 recommendations (10.66%) across 722 answers included in the benchmark. Top 3 placements numbered 55; first-place recommendations numbered 14. Framing among its mentions was 80 positive, 83 neutral and 0 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 1 conflicting claim about Ro: 0 critical, 0 high, 1 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Review topic

Severity

Recorded AI claim A

Recorded AI claim B

monthly price of oral finasteride subscription

medium

$13/month

$16-$30/month

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

Is there something better than Hims?

4

4

4

What is the best hair growth treatment for men?

3

3

3

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://ro.co/hair-loss/finasteride-over-the-counter/.

Selected third-party review candidate: https://myhairline.ai/blog/finasteride-guide-cost-guide.

Ro appears in a moderate share of answers and is endorsed in fewer, with first-place placements rarer still. Its mentions are mostly positive or neutral, so the gap is about endorsement rather than criticism. One medium-severity conflict concerns the monthly price of an oral finasteride subscription, and the two quoted figures may reflect different dates. The agency would verify current pricing from primary sources before any correction, and prepare a conditional page brief for the supplied owned page.

Hims

Questions This Section Answers

  • What measured visibility pattern and review priority does Hims have in Hair Loss Treatments?

Hims recorded 534 mentions (73.96%) and 322 recommendations (44.60%) across 722 answers included in the benchmark. Top 3 placements numbered 262; first-place recommendations numbered 124. Framing among its mentions was 346 positive, 186 neutral and 2 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 3 conflicting claims about Hims: 0 critical, 0 high, 2 medium, 1 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Review topic

Severity

Recorded AI claim A

Recorded AI claim B

monthly price

low

$15–$35+/month

$15–$50+/month

finasteride concentration in topical spray

medium

0.3% finasteride

0.25% finasteride

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

Do Hims and keeps actually work?

6

6

3

What is the best topical finasteride brand?

4

4

3

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://hims.com/hair-loss.

Selected third-party review candidate: https://innerbody.com/nutrafol-vs-hims.

Hims is one of the two most visible brands and is endorsed in a large share of answers, with strong first-place placement. Its mentions are overwhelmingly positive, so the main work is protecting accuracy rather than repairing sentiment. Two medium and one low conflict concern pricing and topical finasteride concentration. The agency would fact-check both against current primary sources, then brief the supplied owned page and the comparison source only where verification supports a change.

Keeps

Questions This Section Answers

  • What measured visibility pattern and review priority does Keeps have in Hair Loss Treatments?

Keeps recorded 239 mentions (33.10%) and 125 recommendations (17.31%) across 722 answers included in the benchmark. Top 3 placements numbered 88; first-place recommendations numbered 14. Framing among its mentions was 142 positive, 95 neutral and 2 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 5 conflicting claims about Keeps: 0 critical, 4 high, 1 medium, 0 low. Of these, 4 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Review topic

Severity

Recorded AI claim A

Recorded AI claim B

ownership / parent company

medium

Owned by CurieMD, a subsidiary of Ro

Separate company, not owned by Hims & Hers (no parent stated)

target audience / gender eligibility

high

Keeps serves men (male pattern baldness)

Keeps serves both men and women

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

Is there something better than Hims?

4

4

4

Do Hims and keeps actually work?

6

6

3

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://keeps.com/.

Selected third-party review candidate: https://dtcetc.com/compare/nutrafol-vs-keeps.

Keeps appears in about a third of answers but is endorsed in roughly half of those appearances, and first-place placements are uncommon. Its framing is largely positive, so the endorsement gap is not explained by negative wording. The conflicts here carry the highest priority in the set, covering ownership and gender eligibility. The agency would resolve the entity and audience facts from primary sources first, since these shape how the brand should be described, then brief the supplied pages conditionally.

Bosley

Questions This Section Answers

  • What measured visibility pattern and review priority does Bosley have in Hair Loss Treatments?

Bosley recorded 56 mentions (7.76%) and 11 recommendations (1.52%) across 722 answers included in the benchmark. Top 3 placements numbered 6; first-place recommendations numbered 2. Framing among its mentions was 13 positive, 43 neutral and 0 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 3 conflicting claims about Bosley: 0 critical, 2 high, 0 medium, 1 low. Of these, 2 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Review topic

Severity

Recorded AI claim A

Recorded AI claim B

merger status / ownership

high

Bosley and HairClub are now uniting/merged

Bosley and HairClub are separate, independent competitors

typical transplant cost

low

$6,000–$12,000+

$4,400–$12,000+

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

Is Bosley better than Rogaine?

3

3

1

Which is better, Bosley or HairClub?

3

3

1

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://bosley.com/blog/which-hair-loss-medication-is-more-effective-rogaine-or-propecia/.

Selected third-party review candidate: https://finvsfin.com/hairclub-vs-bosley/.

Bosley appears in a small share of answers and is endorsed in very few, with almost no first-place placement. Most of its mentions are neutral, which suggests it is named as an option rather than praised. Two high-priority conflicts concern merger status with HairClub, and a low one concerns transplant cost. The agency would verify ownership and cost from primary sources before any correction, and treat the supplied pages as review candidates only.

Folexin

Questions This Section Answers

  • What measured visibility pattern and review priority does Folexin have in Hair Loss Treatments?

Folexin recorded 2 mentions (0.28%) and 2 recommendations (0.28%) across 722 answers included in the benchmark. Top 3 placements numbered 2; first-place recommendations numbered 1. Framing among its mentions was 2 positive, 0 neutral and 0 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 0 conflicting claims about Folexin: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

Are there cheaper alternatives to Nutrafol?

1

1

1

Is there a cheaper alternative to Nutrafol?

1

1

1

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected third-party review candidate: https://reddit.com/r/finehair/comments/1i502wr/has_anyone_found_a_less_expensive_yet_affective/.

Folexin barely registers in this sample, with a handful of appearances and endorsements and no recorded conflicts. That thin evidence supports only a watching brief, not a correction or content programme. The observed questions place it as a cheaper alternative to Nutrafol, which is a useful angle for a small buyer-question brief. The agency would keep it outside the correction queue and revisit it once more answers are captured.

Rogaine

Questions This Section Answers

  • What measured visibility pattern and review priority does Rogaine have in Hair Loss Treatments?

Rogaine recorded 547 mentions (75.76%) and 341 recommendations (47.23%) across 722 answers included in the benchmark. Top 3 placements numbered 269; first-place recommendations numbered 227. Framing among its mentions was 377 positive, 169 neutral and 1 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 0 conflicting claims about Rogaine: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

Is Rogaine better than Nutrafol?

5

5

3

Is Nutrafol better than Rogaine?

4

4

3

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://rogaine.com/collections/mens-products.

Selected third-party review candidate: https://nehair.com/blog/rogaine-vs-nutrafol/.

Rogaine is the most visible brand in the set and leads first-place answers by a wide margin, with almost entirely positive or neutral framing and no recorded conflicts. Its position is strong, so the work is about defending accuracy rather than fixing errors. The observed questions pair it directly against Nutrafol in both directions. The agency would brief the supplied owned page around those head-to-head comparisons and check the third-party comparison source for factual alignment.

HairClub

Questions This Section Answers

  • What measured visibility pattern and review priority does HairClub have in Hair Loss Treatments?

HairClub recorded 40 mentions (5.54%) and 3 recommendations (0.42%) across 722 answers included in the benchmark. Top 3 placements numbered 2; first-place recommendations numbered 0. Framing among its mentions was 4 positive, 36 neutral and 0 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 0 conflicting claims about HairClub: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

Which is better, Bosley or HairClub?

3

3

1

Is HairClub better than Bosley?

2

2

1

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://hairclub.com/blog/5-proven-hair-regrowth-methods-for-men/.

Selected third-party review candidate: https://finvsfin.com/hairclub-vs-bosley/.

HairClub is the clearest case of appearances without endorsement: it is mentioned in a modest share of answers but endorsed in only a handful, with no first-place placements. Most mentions are neutral, so the pattern is naming without praise rather than criticism. No conflicts were recorded. The agency would examine how the brand is described in the supplied pages and the comparison source, and propose a buyer-question brief, without assuming the cause of the gap.

Nutrafol

Questions This Section Answers

  • What measured visibility pattern and review priority does Nutrafol have in Hair Loss Treatments?

Nutrafol recorded 395 mentions (54.71%) and 274 recommendations (37.95%) across 722 answers included in the benchmark. Top 3 placements numbered 203; first-place recommendations numbered 30. Framing among its mentions was 296 positive, 94 neutral and 5 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 0 conflicting claims about Nutrafol: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

Which is better, Nutrafol or Keeps?

4

4

3

What is the best Hair Growth Accelerator?

3

3

3

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://nutrafol.com/.

Selected third-party review candidate: https://rochesterregional.org/hub/hair-loss-treatment-nutrafol.

Nutrafol is strongly visible and frequently endorsed, but first-place placements are comparatively rare, so it is often a recommended option rather than the leading one. Framing is mostly positive with a few negative mentions and no recorded conflicts. The observed questions put it against Keeps and against Rogaine in both directions. The agency would brief the supplied owned page around those comparisons and review the cited third-party pages for accuracy before any request.

Happy Head

Questions This Section Answers

  • What measured visibility pattern and review priority does Happy Head have in Hair Loss Treatments?

Happy Head recorded 220 mentions (30.47%) and 156 recommendations (21.61%) across 722 answers included in the benchmark. Top 3 placements numbered 122; first-place recommendations numbered 10. Framing among its mentions was 176 positive, 44 neutral and 0 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 0 conflicting claims about Happy Head: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What is the best hair product for regrowth?

3

3

3

What is the highest rated hair regrowth product?

3

3

3

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://happyhead.com/products.

Selected third-party review candidate: https://innerbody.com/happy-head-vs-hims.

Happy Head is endorsed in a substantial share of its appearances, but first-place placements are rare, so it is a frequent recommendation rather than a frequent winner. Its framing is positive or neutral with no negative mentions and no recorded conflicts. The observed questions concern best regrowth products, where it is recommended in every captured answer. The agency would brief the supplied owned page to make its positioning easy to restate, and review the comparison source for accuracy.

Propecia (Merck)

Questions This Section Answers

  • What measured visibility pattern and review priority does Propecia (Merck) have in Hair Loss Treatments?

Propecia (Merck) recorded 302 mentions (41.83%) and 105 recommendations (14.54%) across 722 answers included in the benchmark. Top 3 placements numbered 80; first-place recommendations numbered 24. Framing among its mentions was 149 positive, 149 neutral and 4 negative.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

AI answers contained 0 conflicting claims about Propecia (Merck): 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

Does anything work better than ROGAINE?

2

2

2

What is the best hair growth pill for men?

3

2

2

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected third-party review candidate: https://bosley.com/blog/which-hair-loss-medication-is-more-effective-rogaine-or-propecia/.

Propecia (Merck) appears in a large share of answers but is endorsed in only about a third of those appearances, and first-place placements are limited. Its framing is evenly split between positive and neutral, with few negative mentions and no recorded conflicts. The observed questions place it against Rogaine and in best-pill queries. The agency would brief the supplied third-party comparison page and check how the brand is described, without assuming why endorsement lags appearances.

/ Take the next step

Want to Understand Your AI Citation Footprint?

We start every engagement with a full audit of how AI systems reference your brand today.

Measurable, Repeatable Programme

Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge

Citation Architecture Review

Identify which high-authority community sources are and aren't working in your favour across AI platforms.

AI Visibility Audit

Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.

The CiteWorks five-step improvement plan

Step 1. Establish the baseline

Questions This Section Answers

  • What should the agency deliver when it works to establish the baseline for Hair Loss Treatments?

Build a scorecard that records each company's appearances, endorsements and placements exactly as measured, with the screening scope and question set attached. Every entry gets an owner, an evidence requirement and a review status so later editions can be compared on the same basis. This is proposed work, not a record of completed measurement.

Step 2. Verify disputed facts

Questions This Section Answers

  • What should the agency deliver when it works to verify disputed facts for Hair Loss Treatments?

AI answers contained 12 conflicting claims across 4 companies. Another 0 possible conflicts were excluded because their company matches were uncertain. The conflicting claims need fact-checking before any corrections are proposed.

Work through the recorded conflicts company by company, starting with the high-priority ownership and eligibility questions and the pricing and concentration questions. Each needs current primary-source verification of entity, date and source before anyone decides whether a correction is warranted. Ambiguous company matches stay outside the queue, and a resolved conflict may end in a no-change decision.

Step 3. Review owned pages

Questions This Section Answers

  • What should the agency deliver when it works to review owned pages for Hair Loss Treatments?

Turn the supplied owned pages into page briefs that state what should be verified, which buyer questions the page should answer and what evidence supports each statement. Briefs are proposals for review, not instructions to edit. No brief should assert current page contents or company facts that have not been checked against primary sources.

Step 4. Review third-party sources

Questions This Section Answers

  • What should the agency deliver when it works to review third-party sources for Hair Loss Treatments?

Prepare source-review packages for the supplied third-party pages, pairing each with the specific claims it should be checked against. A citation does not show that a page influenced an answer, so requests should rest on verified inaccuracies rather than on appearance counts. Record requests and responses separately from confirmed edits.

Step 5. Address buyer questions and measure again

Questions This Section Answers

  • What should the agency deliver when it works to address buyer questions and measure again for Hair Loss Treatments?

Draft buyer-question content from the questions actually observed, such as head-to-head comparisons and cheaper-alternative queries, and assign each brief to an owner. Measure again on the same screening scope, and report delivered work separately from answer outcomes so neither is mistaken for the other.

Third-party authority and citation opportunities

Questions This Section Answers

  • Which cited publisher pages support targeted source review in Hair Loss Treatments?

Publisher page selected for review

Citation appearances in all captured answers

Companies covered by the page selection

https://finvsfin.com/hairclub-vs-bosley/

3

Bosley, HairClub

https://rochesterregional.org/hub/hair-loss-treatment-nutrafol

39

Nutrafol

https://innerbody.com/viviscal-vs-nutrafol

12

Nutrafol

https://reddit.com/r/finehair/comments/1i502wr/has_anyone_found_a_less_expensive_yet_affective/

12

Folexin

https://nehair.com/blog/rogaine-vs-nutrafol/

11

Rogaine

https://rennorabeauty.com/blogs/news/nutrafol-alternatives

11

Folexin

https://scandinavianbiolabs.co.uk/blogs/hair-loss/nutrafol-vs-rogaine

9

Rogaine

https://innerbody.com/nutrafol-vs-hims

8

Hims

https://bosley.com/blog/which-hair-loss-medication-is-more-effective-rogaine-or-propecia/

6

Propecia (Merck)

https://innerbody.com/happy-head-vs-hims

6

Happy Head

These pages are candidates for review, not confirmed errors. Citation appearances are counted across the captured answers and are not added again for each company.

The publisher list should be prioritized by relevance to the disputed claims and by how many companies each page covers, not by appearance counts alone. Pages touching several brands, such as the Bosley and HairClub comparison, offer broader review value per request, while single-brand pages suit targeted fact checks.

Every candidate needs its current contents verified before any request, since a citation does not establish that a page is inaccurate or influential. The agency would review the highest-relevance pages first, document what each actually says, and only then decide whether a correction request is justified.

What we'd prioritize first

Period

Deliverable

Completion criterion

Days 1–30

Baseline scorecard, scoped fact-review register and page/source shortlist

Each record has an owner, evidence requirement and review status

Days 31–60

Approved page briefs and justified publisher requests

Separate confirmed edits, no-change decisions, requests and responses

Days 61–90

Buyer-content briefs and a fresh scorecard

Record work completed separately from measured answer outcomes and comparability limits

Start with the fact dependencies, because several company sections cannot move until ownership, eligibility, pricing and concentration questions are resolved from primary sources. Keeps and Bosley carry the highest-priority conflicts, so they lead the review queue, with Ro and Hims close behind on pricing and formulation.

In parallel, build the baseline scorecard and the page and source shortlists so every later decision has a traceable record. Buyer-question briefs for the head-to-head comparisons follow once facts are settled. Report completed work separately from measured answer outcomes, and make no promises about gains.

Methodology and conclusion

Questions This Section Answers

  • What do the Hair Loss Treatments sample and source-review limits allow us to conclude?

This edition includes all relevant captured answers, including buyer questions reserved from the limited email report. Every captured answer was screened and every relevant answer was included in the figures. Mentions require the company to be identified in the answer; incidental uses of its name as an ordinary word are not counted. Mentions require the company to be identified in the answer; incidental uses of its name as an ordinary word are not counted. Ahrefs queries return a bounded brand-query sample, not every AI answer available.

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 722 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 6305 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

Reporting month

Answers included

AI services covered

Services

Nov 2026

722

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

July 2026 measured a different set of companies, so it is excluded from this comparison. August 2026 measured a different set of companies, so it is excluded from this comparison. Earlier editions (September 2026 and October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.

Future editions using the same screening scope can be compared against this baseline.

This edition measures a single selected sample of captured answers, and the figures describe that sample rather than a trend. Mentions, endorsements and placements are recorded separately, and an answer can cover several companies, so counts are not additive. The wider citation analysis is a separate view and does not show that any page influenced an answer.

The proposed next steps are a baseline scorecard, verified fact reviews, page and source briefs, and buyer-question content, each tracked by owner and status. Future editions on the same screening scope can be compared against this baseline, with the comparability limit stated alongside any movement.

This analysis is based on the source benchmark: Hair Loss Treatments AI visibility benchmark

/ Learn More

Understanding AI search visibility.

AI search experiences create answers by pulling information from many places online and summarizing it into a single response.

What Is AI Citation Intelligence?
AI citation intelligence is the process of measuring where AI platforms source their information and how frequently a brand is mentioned or referenced in AI-generated responses. Because LLMs synthesize across multiple sources, the sites and brands that appear repeatedly tend to influence how a topic or company is framed. This practice focuses on identifying which sources shape AI outputs and tracking brand visibility across different AI systems.
What Is Citation Architecture?
Citation architecture describes the set of sources that consistently inform how AI systems talk about a brand, product, or topic. LLMs draw from websites, articles, forums, and public discussion, and the sources they rely on most often become the backbone of their answers. Building strong citation architecture means ensuring that accurate, credible, high authority sources are the ones most likely to shape the way AI tools summarize and recommend a brand.
What Is Generative Engine Optimization?
Generative engine optimization (GEO) is the practice of improving the chances that AI systems use and cite your brand or content when generating answers. While traditional SEO is centered on ranking pages in search results, GEO focuses on how LLMs retrieve, interpret, and combine information when responding to a question. The objective is to strengthen the content and sources AI systems rely on, so your brand is treated as a trusted reference in AI responses.
What Is AI Share of Voice?
AI share of voice tracks how often a brand appears in AI-generated answers compared with competitors in the same category. It reflects visibility across AI platforms such as ChatGPT, Gemini, Claude, and Perplexity. Monitoring AI share of voice helps organizations see whether AI systems consistently include and recommend their brand for key queries or whether competitor brands are showing up more often.

About The Author

Mark Huntley

Mark Huntley

Founder and CEO

Mark Huntley, J.D. is founder of CiteWorks Studio, a strategic advisory focused on visibility, authority, and recommendation presence in AI-shaped search environments. His work centers on embedding-level GEO, vector optimization, and cosine gap engineering — helping brands align their digital presence with the retrieval systems that increasingly shape discovery, interpretation, and choice.

Archived editions

Browse earlier published research snapshots for this article. The latest edition remains at the current URL.

VIEW ALL CASE STUDIESREQUEST AN AI VISIBILITY AUDIT